GeneNews Ltd. (GNWSF) Set to Announce Earnings on Wednesday
Shares of GeneNews Ltd. (OTCMKTS:GNWSF) opened at $0.11 on Tuesday. GeneNews Ltd. has a 12-month low of $0.06 and a 12-month high of $0.39. The company has a quick ratio of 0.05, a current ratio of 0.08 and a debt-to-equity ratio of -0.59.
COPYRIGHT VIOLATION WARNING: “GeneNews Ltd. (GNWSF) Set to Announce Earnings on Wednesday” was posted by American Banking News and is the property of of American Banking News. If you are accessing this story on another site, it was illegally copied and republished in violation of international copyright law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2017/11/14/genenews-ltd-gnwsf-set-to-announce-earnings-on-wednesday.html.
GeneNews Limited focuses on developing and commercializing proprietary molecular diagnostic tests for the early detection of diseases and personalized health management with a primary focus on cancer-related indications. Its proprietary platform technology, the Sentinel Principle, identifies novel biomarkers from whole blood.
Receive News & Ratings for GeneNews Ltd. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GeneNews Ltd. and related companies with MarketBeat.com's FREE daily email newsletter.